We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
16/11/2017 20:09 | Black box warning is the most serious indication of potential risks and is very bad for Roche offering a product in an area where treatment safety is absolutely critical | romeike | |
16/11/2017 18:48 | Market were probably expecting approval with no black box warning. What would the share price be here if there had been no FDA approval? Shire's ADYNOVI, expected to be approved in Europe within 60 days. | justiceforthemany | |
16/11/2017 18:39 | In the H1 report haemophilia accounted for 20% of total sales and this is just one drug from that sector so market reaction seems excessive. Clearly the market knew of the Roche approval well in advance hence the daily falls for months now. RE: Roche - I would not want to take a drug with a black box warning! | justiceforthemany | |
16/11/2017 18:23 | Ah right, thought the move was Roche related. As most have been of late. | essentialinvestor | |
16/11/2017 18:23 | Ah , that explains it :-) | philanderer | |
16/11/2017 18:21 | The U.S. Food and Drug Administration on Thursday approved Roche's Hemlibra, a new medicine for haemophilia A that the Swiss drugmaker is counting on to help to offset eroding sales of older medicines going off patent. BUT the FDA slapped Roche's medicine with a black box warning for blood clots, giving a boost to shares in rival Shire, which leads the $11 billion haemophilia drug market with its medicines. | justiceforthemany | |
16/11/2017 18:20 | So this was all to do with one rival drug it seems - FDA has slapped Roche's equivalent with a black box warning | justiceforthemany | |
16/11/2017 18:13 | Can't see much of a shareprice reaction stateside...roughly -1% since London close. UPDATED: In blow to Shire, Roche bags an FDA OK for its blockbuster hemophilia A prospect November 16, 2017 11:35 AM EST | philanderer | |
16/11/2017 17:51 | That's much better today , good volume of 4,488,589 shares traded. | philanderer | |
16/11/2017 17:33 | sold today to take some profits | nimrod22 | |
16/11/2017 17:30 | It's lucky I'm on amlodipine with these types of moves ). Just, double bubble for you today with Hikma. | essentialinvestor | |
16/11/2017 17:24 | 'Specialty biopharmaceutical company Shire was boosted by an upbeat note from Bernstein' A 6% rise just because of an upbeat note from Bernie? What a load of tosh! Someone has heard a whisper at the Jefferies Healthcare conference in London today. | justiceforthemany | |
16/11/2017 16:22 | nice to recoup some losses! where did that come from? | swedeee | |
16/11/2017 16:06 | Bloody hell )). | essentialinvestor | |
16/11/2017 15:59 | Wow - wasn't expecting it to challenge 3,750 this afternoon! | greenrichard | |
16/11/2017 15:56 | Hoping for a close up 6%. Feeling good about all those nice £34 shares. | romeike | |
16/11/2017 15:06 | May be safe to say we are closing higher today! ). | essentialinvestor | |
16/11/2017 14:45 | Spin off plans must finally be here. Searching for take over rumours also. | justiceforthemany | |
16/11/2017 14:40 | Need a close over 3,750 in the next couple of trading sessions to break the downtrend. | greenrichard | |
16/11/2017 13:33 | Bit of a sector bounce today, which seems concentrated on of those that sold off heavily recently. Although GSK is not participating!. Very difficult to judge whether it's a one day wonder or the start of a more sustained price recovery | essentialinvestor | |
16/11/2017 13:24 | PI's have zip influence on the share price | essentialinvestor | |
16/11/2017 10:43 | Most people's averages here will be 4000p+ so no option but to hold. It is the selling on every small spike that causes the frequent pull backs. | justiceforthemany | |
16/11/2017 10:07 | Up 3%!, Phil your guesswork probably better than mine, I'm often too cautious. | essentialinvestor | |
16/11/2017 09:47 | Another false dawn ? Fingers crossed it's the real thing. Well done EI :-) Bit of luck for me too . Was supposed to be flying down to Toulouse today. Put it back until tomorrow a week ago and the good old french have called a national 24 hour strike for today . All flights over french airspace cancelled thursday. | philanderer | |
16/11/2017 08:55 | Sold a few. | essentialinvestor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions